Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the quality standards subcommittee of the american academy of neurology and the practice committee of the child neurology society.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Systematic Review of Clinical Guidelines Related to Care of Individuals With Cerebral Palsy as Part of the World Health Organization Efforts to Develop a Global Package of Interventions for Rehabilitation.Archives of physical medicine and rehabilitation · 2021
   Pooled it
2. Neuropharmacology in pediatric traumatic brain injury.Journal of pediatric rehabilitation medicine · 2026
   Review
3. Effect of psychostimulant medications on physical function in children with cerebral palsy: scoping review.Pediatric research · 2024
   Article
4. Psychostimulant Medications for Physical Function and Spasticity in Children With Cerebral Palsy: Protocol for a Randomized Controlled Trial.JMIR research protocols · 2024
   Article
5. Principles of Medical and Surgical Treatment of Cerebral Palsy.Neurologic clinics · 2020
   Review
6. Best clinical practice in botulinum toxin treatment for children with cerebral palsy.Toxins · 2015
   Review
7. Childhood hemorrhagic stroke: an important but understudied problem.Journal of child neurology · 2011
   Review
8. Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal.Functional neurology
   Review

Corrections and comments

• Comment on
  Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.2010

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as